Document Detail


Usefulness and safety of cimetidine in patients receiving mexiletine for ventricular arrhythmia.
MedLine Citation:
PMID:  3890504     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cimetidine, a commonly used H2 receptor antagonist, was found to adversely interact with many drugs metabolized by the liver, including class I antiarrhythmic agents, lidocaine and quinidine. Mexiletine is a new class I antiarrhythmic agent similar to lidocaine which when used orally may have significant gastric side effects. Since some patients with peptic ulcer disease or gastric hyperacidity on mexiletine may benefit from the addition of cimetidine, it was important to rule out any significant adverse interaction between the two drugs in such patients. Eleven patients currently receiving long-term oral mexiletine for the treatment of complex ventricular arrhythmia underwent a double-blind crossover trial where they were maintained on their usual dose of mexiletine, and cimetidine, 300 mg orally every 6 hours, or placebo were added for a 1-week period each. Peak and trough mexiletine blood levels were not significantly altered by cimetidine. Similarly, there was no significant change in the frequency and severity of ventricular arrhythmia when cimetidine was added to mexiletine. Cimetidine reduced gastric side effects of mexiletine in 50% of patients who had complained of such symptoms on mexiletine alone or on mexiletine and placebo. We conclude that cimetidine can effectively reduce gastric side effects of mexiletine in many patients without adversely affecting the plasma concentration or the efficacy of the drug.
Authors:
A L Klein; M H Sami
Related Documents :
20028914 - Utility of routine barium studies after adjustments of laparoscopically inserted gastri...
3653754 - Relationship between gastric emptying of a solid meal and emptying of the gall bladder ...
8513524 - Interactions of pre-operative erythromycin administration with general anaesthesia.
22449254 - Vitamin d deficiency and changes in serum vitamin d levels with treatment among tubercu...
20041804 - Percutaneous endoscopic gastrostomy in patients with systemic sclerosis.
9291444 - Risk stratification and clinical outcome of minimally symptomatic and asymptomatic pati...
Publication Detail:
Type:  Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American heart journal     Volume:  109     ISSN:  0002-8703     ISO Abbreviation:  Am. Heart J.     Publication Date:  1985 Jun 
Date Detail:
Created Date:  1985-07-16     Completed Date:  1985-07-16     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370465     Medline TA:  Am Heart J     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1281-6     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Arrhythmias, Cardiac / drug therapy*
Cardiovascular System / drug effects
Cimetidine / administration & dosage*,  adverse effects
Clinical Trials as Topic
Double-Blind Method
Drug Interactions
Drug Therapy, Combination
Female
Heart Ventricles
Humans
Male
Mexiletine / administration & dosage*,  adverse effects
Middle Aged
Propylamines / administration & dosage*
Stomach / drug effects
Chemical
Reg. No./Substance:
0/Propylamines; 31828-71-4/Mexiletine; 51481-61-9/Cimetidine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Prostaglandins, immunity and their effect on tumour growth.
Next Document:  The effects on left ventricular performance of verapamil and metoprolol singly and together in exerc...